Copertina

Income‐related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fu‐Shun Yen, James Cheng‐Chung Wei, Wan‐Yi Lu, Yu‐Hsin Yen, Yi‐Ling Wu, Yu‐Ru Lo, Chii‐Min Hwu, Chih‐Cheng Hsu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan
di: Yu‐Hsin Yen, et al.
Pubblicazione: (2024)

Impact of glucagon‐like peptide‐1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes
di: Fu‐Shun Yen, et al.
Pubblicazione: (2025)

Association of initial serum sodium change and clinical outcome in patients with diabetes receiving sodium–glucose cotransporter‐2 inhibitor therapy: A multicentre database analysis in Taiwan
di: Yu‐Wen Cheng, et al.
Pubblicazione: (2024)

Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors
di: Yi‐Wei Kao, et al.
Pubblicazione: (2024)

Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
di: Karen Elkind‐Hirsch, et al.
Pubblicazione: (2025)

Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus
di: Zhuangfei Xu, et al.
Pubblicazione: (2025)

Real‐world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12‐month, prospective observational study
di: Rayaz A. Malik, et al.
Pubblicazione: (2024)

Age‐ and gender‐adjusted estimated glomerular filtration rate definition reveals hyperfiltration as a risk factor for renal function deterioration in type 2 diabetes
di: Wei‐Lun Wen, et al.
Pubblicazione: (2024)

Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study
di: Yun Wang, et al.
Pubblicazione: (2025)

Incidence and progression of diabetic retinopathy in patients treated with glucagon‐like peptide‐1 receptor agonists versus sodium‐glucose cotransporter 2 inhibitors: A population‐based cohort study
di: Donna Shu‐Han Lin, et al.
Pubblicazione: (2024)

Unintentional periconceptional exposure to glucagon‐like peptide‐1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan
di: Yi‐Chang Chou, et al.
Pubblicazione: (2025)

Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study
di: Tzu‐Yang Chen, et al.
Pubblicazione: (2024)

Risk of depression with GLP ‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study
di: Yu Chang, et al.
Pubblicazione: (2025)

Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study
di: Ya‐Hui Yu, et al.
Pubblicazione: (2024)

Semaglutide attenuates diabetic retinopathy progression via ameliorating retinal vasculopathy and oxidative stress in vivo and in vitro
di: Xiao Cheng, et al.
Pubblicazione: (2025)

Taste perception genomics in gestational diabetes mellitus: A systematic review
di: Vishnu Shivam, et al.
Pubblicazione: (2024)

Body mass index trajectories and time in target range after delivery and long‐term type 2 diabetes risk in women with a history of gestational diabetes mellitus
di: Lixia Zhang, et al.
Pubblicazione: (2024)

A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
di: Jiewen Guan, et al.
Pubblicazione: (2025)

Effects of intensive treatment of Chinese women with gestational diabetes on the risk of offspring being overweight from 3 to 8 years of age
di: Jing Li, et al.
Pubblicazione: (2024)

Clinical effectiveness and cost‐effectiveness of first‐line early combination of dipeptidyl peptidase 4 inhibitors and metformin in patients with type 2 diabetes in Taiwan: A modelling study
di: Thi Thuy Dung Nguyen, et al.
Pubblicazione: (2025)

Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus
di: Ida M. Gether, et al.
Pubblicazione: (2024)

Pregnancy and postpartum cardiometabolic outcomes among women with overt diabetes compared to women with normoglycaemia, gestational diabetes and pre‐existing diabetes: A systematic review and meta‐analysis
di: Adarsh Pal, et al.
Pubblicazione: (2025)

Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention
di: Pei Chia Eng, et al.
Pubblicazione: (2024)

Treating class 2–3 obesity with glucagon‐like peptide‐1 agonists: A 2‐year real‐world cohort study
di: Mona Abdel‐Bary, et al.
Pubblicazione: (2025)

Metformin lowers risk of hearing loss and mortality in type 2 diabetes
di: Chun‐Chih Huang, et al.
Pubblicazione: (2024)

Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial
di: Shamini Murugavel, et al.
Pubblicazione: (2025)

Chemerin loss‐of‐function attenuates glucagon‐like peptide‐1 secretion in exercised obese mice
di: Qilong Zhang, et al.
Pubblicazione: (2025)

Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
di: Yu‐Nan Huang, et al.
Pubblicazione: (2024)

Comparing clinical outcomes of adults with obesity receiving tirzepatide versus bariatric metabolic surgery: A multi‐institutional propensity score‐matched study
di: Jheng‐Yan Wu, et al.
Pubblicazione: (2025)

Methodological Concerns Regarding BMI Imbalance and Competing Risks in a Head‐to‐Head Comparison of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists for Incident Dementia
di: Shio‐Shin Jean, et al.
Pubblicazione: (2026)

The interaction effect between BMI , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China
di: Tianzhichao Hou, et al.
Pubblicazione: (2024)

Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
di: Hsiao‐Ling Chen, et al.
Pubblicazione: (2024)

Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes
di: Resham Lal Gurung, et al.
Pubblicazione: (2025)

Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies
di: Rajna Golubic, et al.
Pubblicazione: (2024)

The cardio‐metabolic protein profile is associated with development of type 2 diabetes at long term follow‐up after gestational diabetes mellitus: Results from the OGFUS study
di: Simone J. Hallig, et al.
Pubblicazione: (2025)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
di: Moses Yidong Lim, et al.
Pubblicazione: (2026)

Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus‐affected pregnancy
di: Majken Lillholm Pico, et al.
Pubblicazione: (2025)

Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
di: Scott A. Coon, et al.
Pubblicazione: (2025)

Real‐world predictors of progression to type 2 diabetes among adults with prediabetes
di: Tyler Dunn, et al.
Pubblicazione: (2026)

The protective role of TIGIT + B cells in attenuating type 1 diabetes progression
di: Yiman Peng, et al.
Pubblicazione: (2025)